Philips, BioIntelliSense and University of Colorado receive U.S. Department of Defense funding for early COVID-19 detection - Press Release
December 22, 2020 Cambridge, MA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and BioIntelliSense, Inc. [1], a continuous health monitoring and clinical intelligence company, today announced they have been selected by the U.S. Army Medical Research and Development Command (USAMRDC) to receive nearly USD 2.8 million from the U.S. Department of Defense (DoD) through a Medical Technology Enterprise Consortium (MTEC) award to validate BioIntelliSense’s FDA-cleared BioSticker device for the early detection of COVID-19 symptoms. The goal of the award is to accel...
Source: digitaljournal.com